Latest Period
Q2 2026
Security Snapshot
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) Institutional Ownership
CUSIP: 68621F102
13F Institutional Holders and Ownership History from Q4 2018 to Q2 2026
Institutions Reporting
134
Shares (Excl. Options)
66,040,560
Price
$2.43
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 par value
- Symbol
- ORGO on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 66,040,560
- Total 13F value
- $160,447,672
- Portfolio coverage rank
- 0%
- Share change
- +4,268,676
- Value change
- +$10,604,315
- Number of holders
- 134
- Shares outstanding
- 127,085,490
- SEC-reported price per share
- $2.68
- Insider filing price
- $2.68
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value is tracked under CUSIP 68621F102.
- 134 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 117 to 134 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $146,051,135 to $160,447,672.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 134 institutions filings for Q2 2026.
Security key
68621F102
Latest holder period
Q2 2026
13F holders
134
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
ORGO full holder history
Organogenesis Holdings Inc. SEC filings
Organogenesis Holdings Inc. company facts
Organogenesis Holdings Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68621F102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
ORGO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ades Alan A. | 18% | -1.1% | $66,289,913 | 22,319,836 | 0% | Alan A. Ades | 24 Jun 2025 | |
| NUSSDORF GLENN H | 9.7% | $51,688,923 | 12,248,560 | Glenn H. Nussdorf | 14 May 2025 | |||
| Soleus Capital Master Fund, L.P. | 7.9% | -20% | $42,040,854 | -$10,520,474 | 9,985,951 | -20% | Soleus Capital Master Fund, L.P. | 31 Dec 2025 |
| First Light Asset Management, LLC | 3.1% | -50% | $16,371,915 | -$18,610,675 | 3,888,816 | -53% | Mathew P. Arens | 31 Dec 2025 |
As of 30 Jun 2026, 134 institutional investors reported holding 66,040,560 shares of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO). This represents 52% of the company’s total 127,085,490 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
47%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 9.2% | 11,721,609 | +0.9% | 0% | $28,483,510 |
| Soleus Capital Management, L.P. | 8% | 10,140,951 | +0.55% | 0.85% | $24,642,511 |
| BlackRock, Inc. | 5.7% | 7,249,528 | +48% | 0% | $17,616,354 |
| DIMENSIONAL FUND ADVISORS LP | 2.4% | 3,050,297 | +5.5% | 0% | $7,412,123 |
| AQR CAPITAL MANAGEMENT LLC | 2.4% | 3,011,753 | +242% | 0% | $7,318,559 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3% | 2,905,919 | +0.18% | 0% | $7,061,383 |
| D. E. Shaw & Co., Inc. | 2.3% | 2,888,313 | +26% | 0% | $7,018,601 |
| Assenagon Asset Management S.A. | 1.5% | 1,967,952 | 0% | 0.01% | $4,782,123 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 1,935,554 | +8.5% | 0% | $4,704,612 |
| DEUTSCHE BANK AG\ | 1.3% | 1,706,186 | +0.03% | 0% | $4,146,032 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3% | 1,607,729 | +11% | 0% | $3,906,781 |
| ACADIAN ASSET MANAGEMENT LLC | 1.2% | 1,545,086 | -2% | 0% | $3,749,000 |
| STATE STREET CORP | 1.2% | 1,519,955 | -0.34% | 0% | $3,693,491 |
| RENAISSANCE TECHNOLOGIES LLC | 0.8% | 1,017,113 | -4.8% | 0% | $2,471,585 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.71% | 905,024 | +2.9% | 0% | $2,199,208 |
| GOLDMAN SACHS GROUP INC | 0.7% | 887,399 | +71% | 0% | $2,156,380 |
| CITADEL ADVISORS LLC | 0.68% | 867,929 | +59% | 0% | $2,109,067 |
| SG Americas Securities, LLC | 0.61% | 772,737 | -2.3% | 0% | $1,878,000 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.54% | 692,197 | 0.01% | $1,682,039 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.49% | 628,700 | 0% | $1,527,741 | |
| NORTHERN TRUST CORP | 0.46% | 584,577 | +5.4% | 0% | $1,420,522 |
| BANK OF AMERICA CORP /DE/ | 0.44% | 563,048 | +2.7% | 0% | $1,368,206 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.43% | 550,000 | 0% | 0.19% | $1,336,500 |
| NORGES BANK | 0.42% | 530,900 | 0% | $1,290,087 | |
| VANGUARD FIDUCIARY TRUST CO | 0.39% | 495,363 | -0.62% | 0% | $1,203,732 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
31
Latest
Q2 2026
Rows shown
1-25 of 31
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 66,040,560 | $160,447,672 | +$10,604,315 | $2.43 | 134 |
| 2026 Q1 | 61,633,029 | $146,051,135 | -$27,867,171 | $2.37 | 117 |
| 2025 Q4 | 69,509,561 | $359,884,065 | +$3,813,170 | $5.18 | 147 |
| 2025 Q3 | 68,366,364 | $288,461,825 | -$3,867,059 | $4.22 | 119 |
| 2025 Q2 | 69,383,599 | $253,970,094 | +$15,169,482 | $3.66 | 113 |
| 2025 Q1 | 64,527,988 | $278,764,897 | +$10,290,470 | $4.32 | 135 |
| 2024 Q4 | 62,559,435 | $200,195,689 | -$4,632,565 | $3.20 | 119 |
| 2024 Q3 | 63,992,032 | $183,024,939 | +$3,073,151 | $2.86 | 111 |
| 2024 Q2 | 62,887,604 | $176,087,539 | +$15,313,422 | $2.80 | 114 |
| 2024 Q1 | 57,059,906 | $162,044,497 | -$4,218,961 | $2.84 | 123 |
| 2023 Q4 | 58,271,447 | $238,328,151 | +$24,483,565 | $4.09 | 107 |
| 2023 Q3 | 52,567,125 | $167,155,866 | +$2,434,079 | $3.18 | 103 |
| 2023 Q2 | 51,683,797 | $171,584,944 | -$2,458,393 | $3.32 | 111 |
| 2023 Q1 | 53,442,433 | $113,798,804 | -$5,356,219 | $2.13 | 130 |
| 2022 Q4 | 56,005,330 | $150,650,419 | +$1,931,028 | $2.69 | 146 |
| 2022 Q3 | 55,031,412 | $178,300,322 | -$19,442,671 | $3.24 | 144 |
| 2022 Q2 | 58,051,832 | $283,327,408 | -$3,172,672 | $4.88 | 140 |
| 2022 Q1 | 57,887,989 | $440,942,195 | +$10,319,977 | $7.62 | 147 |
| 2021 Q4 | 55,836,563 | $515,731,659 | -$2,571,363 | $9.24 | 151 |
| 2021 Q3 | 53,370,851 | $762,477,663 | +$42,467,188 | $14.24 | 141 |
| 2021 Q2 | 49,939,204 | $830,012,497 | +$410,032,084 | $16.62 | 140 |
| 2021 Q1 | 24,855,592 | $453,129,001 | +$68,036,540 | $18.22 | 99 |
| 2020 Q4 | 21,338,757 | $160,687,218 | +$122,816,812 | $7.53 | 65 |
| 2020 Q3 | 4,977,699 | $19,103,728 | +$2,285,403 | $3.84 | 47 |
| 2020 Q2 | 4,380,098 | $16,755,945 | +$2,234,312 | $3.84 | 47 |